Methods for inhibition of HIV replication using a small molecule inhibitor
View Patent ↗Methods are provided for inhibiting or suppressing viral replication in an infected host cell. More specifically, methods are provided for inhibiting or suppressing viral replication in an infected host cell by administering compounds that interfere with the binding of C-X-C chemokines to C-X-C chemokine receptors. Such methods are advantageous for treating viral infections such as human immunodefeciency virus infections.
1. A method of suppressing viral replication in a human patient having an HIV viral infection, the method comprising administering to the human patient having the HIV viral infection a therapeutically effective amount, to suppress HIV viral replication, of a non-peptide small molecule inhibitor which blocks or interferes with or prevents the binding of at least one C-X-C chemokine with at least one C-X-C chemokine receptor selected from the group consisting of CXCR1, CXCR2 and CXCR3.
2. The method of claim 1 , wherein the non-peptide small molecule inhibitor is N-(2-hydroxy-4-nitrophenyl)-N′-(2-bromophenyl)urea.
3. The method of claim 1 , wherein the C-X-C chemokine is selected from the group consisting of IL-8, GRO-α and IP-10.
4. A method of suppressing viral replication in a human patient having a viral infection, the method comprising administering to said human patient having a viral infection a therapeutically effective amount, to suppress viral replication, of a small molecule inhibitor which blocks, interferes with or prevents the binding of at least one C-X-C chemokine with at least one C-X-C chemokine receptor selected from the group consisting of CXCR1, CXCR2 and CXCR3; and
wherein said small molecule inhibitor comprises N-(2-hydroxy-4-nitrophenyl)-N′-(2-bromophenyl)urea of formula (I):
5. The method of claim 4 , wherein said viral infection is an HIV infection.